Literature DB >> 18023418

Identification of a novel substrate for TNFalpha-induced kinase NUAK2.

Hiroyuki Yamamoto1, Seiji Takashima, Yasunori Shintani, Satoru Yamazaki, Osamu Seguchi, Atsushi Nakano, Shuichiro Higo, Hisakazu Kato, Yulin Liao, Yoshihiro Asano, Tetsuo Minamino, Yasushi Matsumura, Hiroshi Takeda, Masafumi Kitakaze.   

Abstract

TNFalpha has multiple important cellular functions both in normal cells and in tumor cells. To explore the role of TNFalpha, we identified NUAK family, SNF1-like kinase 2 (NUAK2), as a TNFalpha-induced kinase by gene chip analysis. NUAK2 is known to be induced by various cellular stresses and involved in cell mortality, however, its substrate has never been identified. We developed original protocol of de novo screening for kinase substrates using an in vitro kinase assay and high performance liquid chromatography (HPLC). Using this procedure, we identified myosin phosphatase target subunit 1 (MYPT1) as a specific substrate for NUAK2. MYPT1 was phosphorylated at another site(s) by NUAK2, other than known Rho-kinase phosphorylation sites (Thr696 or Thr853) responsible for inhibition of myosin phosphatase activity. These data suggests different phosphorylation and regulation of MYPT1 activity by NUAK2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18023418     DOI: 10.1016/j.bbrc.2007.11.013

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

Review 1.  The LKB1 complex-AMPK pathway: the tree that hides the forest.

Authors:  Michaël Sebbagh; Sylviane Olschwang; Marie-Josée Santoni; Jean-Paul Borg
Journal:  Fam Cancer       Date:  2011-09       Impact factor: 2.375

2.  The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-β signaling.

Authors:  Kaku Goto; Wenyu Lin; Leiliang Zhang; Nikolaus Jilg; Run-Xuan Shao; Esperance A K Schaefer; Hong Zhao; Dahlene N Fusco; Lee F Peng; Naoya Kato; Raymond T Chung
Journal:  J Hepatol       Date:  2013-07-02       Impact factor: 25.083

3.  The AMPK-related kinase SNARK regulates muscle mass and myocyte survival.

Authors:  Sarah J Lessard; Donato A Rivas; Kawai So; Ho-Jin Koh; André Lima Queiroz; Michael F Hirshman; Roger A Fielding; Laurie J Goodyear
Journal:  J Clin Invest       Date:  2016-02       Impact factor: 14.808

4.  AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma.

Authors:  Takeshi Namiki; Atsushi Tanemura; Julio C Valencia; Sergio G Coelho; Thierry Passeron; Masakazu Kawaguchi; Wilfred D Vieira; Masashi Ishikawa; Wataru Nishijima; Toshiyuki Izumo; Yasuhiko Kaneko; Ichiro Katayama; Yuji Yamaguchi; Lanlan Yin; Eric C Polley; Hongfang Liu; Yutaka Kawakami; Yoshinobu Eishi; Eishi Takahashi; Hiroo Yokozeki; Vincent J Hearing
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-01       Impact factor: 11.205

5.  Expression of NUAK2 in gastric cancer tissue and its effects on the proliferation of gastric cancer cells.

Authors:  Lin Tang; Shu-Juan Tong; Zhen Zhan; Qian Wang; Yuan Tian; Feng Chen
Journal:  Exp Ther Med       Date:  2016-12-19       Impact factor: 2.447

6.  Comparison of gene expression profiles in chromate transformed BEAS-2B cells.

Authors:  Hong Sun; Harriet A Clancy; Thomas Kluz; Jiri Zavadil; Max Costa
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

7.  The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.

Authors:  David B Shackelford; Reuben J Shaw
Journal:  Nat Rev Cancer       Date:  2009-08       Impact factor: 60.716

Review 8.  NUAK2: an emerging acral melanoma oncogene.

Authors:  Takeshi Namiki; Sergio G Coelho; Vincent J Hearing
Journal:  Oncotarget       Date:  2011-09

9.  Muscle-specific knock-out of NUAK family SNF1-like kinase 1 (NUAK1) prevents high fat diet-induced glucose intolerance.

Authors:  Fumika Inazuka; Naoyuki Sugiyama; Masaru Tomita; Takaya Abe; Go Shioi; Hiroyasu Esumi
Journal:  J Biol Chem       Date:  2012-03-14       Impact factor: 5.157

10.  Meglumine exerts protective effects against features of metabolic syndrome and type II diabetes.

Authors:  Arturo Bravo-Nuevo; Alice Marcy; Minzhou Huang; Frank Kappler; Jennifer Mulgrew; Lisa Laury-Kleintop; Melvin Reichman; Annette Tobia; George C Prendergast
Journal:  PLoS One       Date:  2014-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.